MiniMed Group, Inc. (MMED) Stock Forecast
MMED analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.38 / 5 from 16 analysts
- Price target
- $25.19 average of analyst targets
- Upside to target
- +44.0% from the latest close
- Next earnings
- —
- 52-week range
- $10.80 – $23.84
MMED analyst ratings
16 analystsNumber of analysts at each rating.
MMED price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MMED earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $0.11 | $0.07 | $0.14 | — | — | 10 |
| Next quarter (Jan '27) | $0.20 | $0.18 | $0.22 | $0.08 | +170.7% | 10 |
| Current fiscal year (FY2027) | $0.70 | $0.62 | $0.77 | −$0.56 | +225.7% | 11 |
| Next fiscal year (FY2028) | $0.69 | $0.40 | $0.97 | $0.70 | −0.9% | 11 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MMED revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Oct '26) | $824.4M | $813.9M | $832.0M | — | 13 |
| Next quarter (Jan '27) | $860.6M | $856.1M | $869.0M | +8.9% | 12 |
| Current fiscal year (FY2027) | $3.44B | $3.43B | $3.47B | +16.3% | 16 |
| Next fiscal year (FY2028) | $3.73B | $3.67B | $3.82B | +8.4% | 16 |
MMED EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MMED revenue: reported and forecast
MMED EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $0.14 | $0.14 | $0.13 | $0.12 | $0.11 | −23.6% | 0 up · 3 down |
| Next quarter (Jan '27) | $0.16 | $0.16 | $0.20 | $0.20 | $0.20 | +25.5% | 5 up · 0 down |
| Current fiscal year (FY2027) | $0.63 | $0.62 | $0.67 | $0.67 | $0.70 | +11.4% | 1 up · 0 down |
| Next fiscal year (FY2028) | $0.66 | $0.66 | $0.64 | $0.64 | $0.69 | +5.1% | 2 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MMED earnings surprises
Reported EPS vs the consensus estimate for the last 3 quarters; MMED beat in 1 of 3.
What analysts expect from MMED
16 analysts cover MiniMed; their consensus rating is buy (4.38 on a 1–5 scale, where 5 is a strong buy). The average price target is $25.19, 44.0% above the latest close of $17.49. Analysts expect earnings of $0.70 per share for FY2027, +225.7% from a year earlier. For FY2028 the average estimate is $0.69 per share on revenue of $3.7 billion. MiniMed beat the EPS estimate in 1 of the last 3 quarters.
Related: MMED income statement, MMED key metrics, MMED chart. See the MMED stock overview for the latest quote and news.
MMED forecast FAQ
What is MiniMed's price target?
The average analyst price target for MiniMed is $25.19, 44.0% above the latest close of $17.49.
Is MiniMed a buy, hold or sell?
Of 16 analysts covering MiniMed, 11 rate it a strong buy, 1 a buy, 3 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is MiniMed's EPS forecast?
Analysts forecast $0.70 per share for FY2027 (range $0.62 to $0.77); for FY2028 the estimate is $0.69.
What is MiniMed's revenue forecast?
The average revenue estimate for FY2027 is $3.4 billion, growth of 16.3%; for FY2028 it is $3.7 billion.
Does MiniMed usually beat earnings estimates?
MiniMed reported EPS at or above the analyst estimate in 1 of the last 3 quarters.